Case Studies and Noteworthy Articles

CASE STUDY

Private Health researchers and clinicians published a case study in the journal Clinical Colorectal Cancer, highlighting the importance of molecular profiling to identify precision, life-changing medicines to patients.

 CASE STUDY

In this case study, published by Private Health researchers, illustrates the capacity of genomic profiling to uncover molecular drivers of disease and help ensure proper diagnosis and management of cancer.

NOTEWORTHY

New York Times journalist Nelson Schwartz features Private Health’s cutting edge cancer research noting "Even the best specialists don't have a dedicated research department …nor do they have time to go through the 60,000 articles that appear in the medical journals each month."

FAMILY WEALTH REPORT

Newsworthy Image Bank-16.jpg

Private Health shortlisted for prestigious Family Wealth Report Awards 2020 – Health care Services

NOTEWORTHY

Leslie Michelson's book provides actionable steps and practical tools that will empower readers everywhere to achieve the best possible health outcomes at every stage of life.

NEW YORK TIMES

White Collar Quarantine Over Virus Spotlights Class Divide

REAL SIMPLE

9 Simple, Stress-Free Ways to Manage Your Health Care

WORKFORCE.COM

The 4 Myths of Health Care Cost Reduction

BUSINESS OF HEALTHCARE PODCAST

The Business of Healthcare Podcast: How to Become a More Effective Healthcare Consumer

ROBB REPORT

Why Women Aren’t Getting the Care They Need

VOYAGE LA

Meet Leslie Michelson of Private Health Management

FOX NEWS

Protect your best interests with the Patient’s Playbook

ABC GOOD MORNING AMERICA

The Patient’s Playbook: A Guide for the Health Care System

TIME

5 Tips for Getting the Most out of your Healthcare

THE WALL STREET JOURNAL 

Medical Quarterbacking: Providers are drowning in patients. As a result, you need to fight tenaciously to make sure that you get the best care.

BARRON'S

Wealthy Increasingly Hire Pricey Health Care Consultants

THE WALL STREET JOURNAL

Leslie Michelson: Doctor to the 1% (and maybe someday to you)